All Reports Events Blogs Videos
Showing 36 results
  • PEAK Matrix®
    Dec. 08, 2023

    Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by harnessing digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results…
  • Provider Compendium
    Dec. 12, 2022

    Decentralized Clinical Trials (DCTs), in which clinical trial data is collected through sensors or remote monitoring devices, can deliver many benefits to pharmaceutical companies, including cost savings, better patient recruitment and retention, flexibility in operations, and…
  • Provider Compendium
    Nov. 21, 2022

    The pandemic necessitated and accelerated the rapid adoption of digital services across the Life Sciences (LS) value chain. As a result, there has been a shift in enterprise mindset to become more customer-centric and invest in…
  • PEAK Matrix®
    Nov. 09, 2022

    Decentralized Clinical Trials (DCTs), in which clinical trial data is collected through sensors or remote monitoring devices, can deliver many benefits to pharmaceutical companies, including cost savings, better patient recruitment and retention, flexibility in operations, and…
  • PEAK Matrix®
    Sep. 27, 2022

    The pandemic necessitated and accelerated the rapid adoption of digital services across the Life Sciences (LS) value chain. Therefore, there has been a conscious shift in enterprise mindset to focus on delivering products and services in…
  • Provider Compendium
    Aug. 05, 2021

    Decentralized Clinical Trials (DCTs), in which clinical trial data is collected through sensors or remote monitoring devices carried by a patient without the need to visit a site, can deliver many benefits to pharmaceutical companies, including…
  • PEAK Matrix®
    July 16, 2021

    Decentralized Clinical Trials (DCTs), in which clinical trial data is collected through sensors or remote monitoring devices carried by a patient without the need to visit a site, can deliver many benefits to pharmaceutical companies, including…
  • Provider Compendium
    Feb. 12, 2021

    The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, ranging from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. There has also been a…
  • PEAK Matrix®
    Dec. 10, 2020

    The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. The industry was already growing significantly…
  • State of the Market
    March 04, 2020

    Now more than ever, the healthcare provider industry is expected to improve care outcomes, keep pace with changing regulatory policies, and stay competitive in the face of disruptions, all the while keeping healthcare costs in check.…
  • PEAK Matrix®
    Dec. 20, 2019

    The payer industry is facing several issues such as escalating costs, declining margins, widespread regulatory amendments, shift from volume- to value-based care model, and rising consumerism. Digital adoption is influencing all aspects of the payer value…
  • PEAK Matrix®
    Dec. 13, 2019

    Healthcare challenges, such as changing business and care delivery models to support patient-centricity and consumerism, growing competition from both within and outside the industry, and increasing regulatory pressures, are leading to increased investments in data and…
  • PEAK Matrix®
    Sep. 13, 2019

    The life sciences industry is plagued by issues such as high time-to-market for drugs and high costs of drug development. Enterprises have prioritized digital technologies in their corporate strategies to optimize processes, reduce costs, and positively…
  • PEAK Matrix®
    Aug. 28, 2018

    The Life Sciences (LS) industry is now beginning to look at digital transformation more seriously. The European LS market has a number of distinctive characteristics, including price regulations, need for General Data Protection Regulation (GDPR) and…
  • PEAK Matrix®
    June 15, 2018

    The Life Sciences (LS) industry is now beginning to look at digital transformation seriously. With the advent of omni-channel information through IoT devices, mobility, and social media, consumers are gaining access to innovative ways of managing…
  • Thematic Report
    March 01, 2018

    The United States healthcare market experienced a tectonic shift in 2017, with President Trump’s (thus far unsuccessful) pursuit to repeal the Affordable Care Act (ACA) and replace it with a new law. Given the uncertainty of…
  • PEAK Matrix®
    Nov. 30, 2017

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • PEAK Matrix®
    Oct. 27, 2017

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • PEAK Matrix®
    May 31, 2017

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • PEAK Matrix®
    Nov. 30, 2016

    The healthcare landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with mobile computing, social media…

Items per page